首页 › 基金 › Cormorant Asset Management, LP › GPCR
Cormorant Asset Management, LP 对 GPCR 的持仓历史
STRUCTURE THERAPEUTICS INC · 医疗保健
Cormorant Asset Management, LP 在 Q2 2026 的 13F 申报中披露持有 GPCR(STRUCTURE THERAPEUTICS INC)75,000 股,市值约 US$4.0M,约占其申报组合的 0.21%,在其申报持仓中市值排名第 42 位。 Cormorant Asset Management, LP 最近 12 个申报季度中有 3 个季度披露了 GPCR 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Cormorant Asset Management, LP 对 GPCR 的持仓演变
Cormorant Asset Management, LP 于 Q3 2023 首次披露 GPCR 持仓:1,056,373 股(约 US$53.3M)。 在 3 次申报中,Cormorant Asset Management, LP 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 75,000 股、市值约 US$4.0M,环比减持 -100,000 股。。 持仓曾出现大幅变动:Q2 2026 减持约 57% (随后一个季度股价下跌 42%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.06M | $53.26M | 新进 |
| Q1 2026 | 175.00K | $8.44M | 新进 |
| Q2 2026 | 75.00K | $4.03M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GPCR 与 13F 数据
GPCR(STRUCTURE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 GPCR,申报仓位最大的包括:Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GPCR 的基金
- Avoro Capital Advisors LLC 6.56M 股 · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M 股 · $254.40M · Q2 2026
- BVF INC/IL 3.37M 股 · $180.70M · Q2 2026
- ORBIMED ADVISORS LLC 2.21M 股 · $118.58M · Q2 2026
- RTW INVESTMENTS, LP 1.61M 股 · $86.27M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M 股 · $76.88M · Q2 2026
- Casdin 资本 1.18M 股 · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M 股 · $58.29M · Q2 2026
- Siren, L.L.C. 872.97K 股 · $46.85M · Q2 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K 股 · $42.94M · Q2 2026
- Rock Springs Capital Management LP 640.32K 股 · $34.37M · Q2 2026
- Logos Global Management LP 500.00K 股 · $26.84M · Q2 2026
更多关于 Cormorant Asset Management, LP
常见问题
How long has Cormorant Asset Management, LP held GPCR?
Cormorant Asset Management, LP has disclosed GPCR holdings in 3 of the last 12 reported quarters, going back to Q3 2023.
What is Cormorant Asset Management, LP's current position in GPCR?
As of Q2 2026, Cormorant Asset Management, LP holds 75.00K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $4.03M, representing 0.21% of its reported portfolio and ranking #42.
Has Cormorant Asset Management, LP been buying or selling GPCR?
In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in GPCR.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.